Neocare (Tretinoin)

Tretinoin binds to nuclear retinoic acid receptors (RAR‑α, RAR‑β, RAR‑γ) in epidermal cells, modulating gene expression that controls keratinocyte proliferation, differentiation and apoptosis. This normalizes desquamation, reduces follicular plugging, and stimulates collagen synthesis, leading to clearer skin and improved texture.

The dosage and frequency of Neocare are set by the prescribing clinician based on the severity of the condition, skin type and tolerance. Typical regimens start with a low‑strength application once daily or every other night, with adjustments made according to clinical response.

Tretinoin is classified as a potential teratogen, and its use is generally avoided during pregnancy. Limited data exist for breastfeeding, so discontinuation is recommended if a patient is nursing. Physicians should discuss alternative therapies when pregnancy or lactation is a concern.

To place an order, submit an enquiry on the Neocare product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neocare (tretinoin) is a retinoid that directly influences skin cell turnover, whereas agents such as benzoyl peroxide act as antibacterial oxidizers. Compared with oral isotretinoin, topical tretinoin offers localized efficacy with fewer systemic effects, making it suitable for milder to moderate acne.

Neocare should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity, which could degrade the active ingredient.

Apply a thin layer of Neocare to clean, dry skin once daily or as directed by the prescriber, typically in the evening. Avoid the eye area, lips and any broken or inflamed skin. Wash hands after application and follow with a moisturizer if recommended.

Serious adverse events, though rare, include severe dermatitis, blistering, Stevens‑Johnson syndrome, toxic epidermal necrolysis and marked photosensitivity leading to severe sunburn. Additionally, systemic absorption may pose a teratogenic risk, so pregnancy must be avoided during treatment.

Neocare is contraindicated in patients who are pregnant, have known hypersensitivity to tretinoin or any formulation excipients, or have severely compromised or inflamed skin at the intended site of application. Caution is also advised for individuals with a history of severe photosensitivity.